0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Antipyretic Analgesics Market Research Report 2024
Published Date: January 2024
|
Report Code: QYRE-Auto-18O9126
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global Antipyretic Analgesics Market Outlook 2022
BUY CHAPTERS

Global Antipyretic Analgesics Market Research Report 2024

Code: QYRE-Auto-18O9126
Report
January 2024
Pages:96
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Antipyretic Analgesics Market Size

The global Antipyretic Analgesics market was valued at US$ 2781.6 million in 2023 and is anticipated to reach US$ 3026.9 million by 2030, witnessing a CAGR of 1.2% during the forecast period 2024-2030.

Antipyretic Analgesics Market

Antipyretic Analgesics Market

Antipyretic Analgesics (algesics) are drugs that can make the body temperature of a febrile patient return to normal, but have no effect on normal body temperature. These drugs also have moderate analgesic effects, but not as strong as morphine and its synthetic substitutes. Commonly used antipyretic and analgesic drugs can be divided into salicylic acid, aniline and pyrazolone according to their chemical structure. Among them, except aniline drugs have anti-rheumatic effect, but also can treat rheumatism and rheumatoid arthritis.
From the perspective of product market application, adult antipyretic and analgesic drugs occupy the vast majority of product market application.
Antipyretic analgesic of the world's main producers have Mallinckrodt Pharmaceuticals, IOL, ruan pharmaceutical, Novacyl, basf, bbca pharmaceutical, hubei hundred Cohen di pharmaceutical co., LTD., xinhua pharmaceutical, Granules India Limited, changshu port of China, hebei JiHeng, zhejiang kangle pharmaceutical company, the professional medical technology co., LTD. Hebei province and hunan zhongnan pharmaceutical co., LTD., etc., together with the market share of around 60%.
This report aims to provide a comprehensive presentation of the global market for Antipyretic Analgesics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antipyretic Analgesics.

Report Scope

The Antipyretic Analgesics market size, estimations, and forecasts are provided in terms of sales volume (MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Antipyretic Analgesics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Antipyretic Analgesics manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Antipyretic Analgesics Market Report

Report Metric Details
Report Name Antipyretic Analgesics Market
Accounted market size in 2023 US$ 2781.6 million
Forecasted market size in 2030 US$ 3026.9 million
CAGR 1.2%
Base Year 2023
Forecasted years 2024 - 2030
Segment by Type
  • Paracetamol
  • Aspirin
  • Ibuprofen
  • Naproxen
  • Diclofenac
  • Oxaprozin
  • Dexibuprofen
  • Others
Segment by Application
  • Adults
  • Children
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Mallinckrodt Pharmaceuticals, IOL, Anqiu Lu'an Pharmaceutical, Novacyl, BASF, Anhui BBCA Pharmaceuticals, Hubei Biocause, Xinhua Pharm, Granules India Limited, Huagang Pharm, Hebei Jiheng Pharmaceutical, Zhejiang Kangle Pharmaceutical, Hebei Jingye Medical Technology, MSPF
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Antipyretic Analgesics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Antipyretic Analgesics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Antipyretic Analgesics Market growing?

Ans: The Antipyretic Analgesics Market witnessing a CAGR of 1.2% during the forecast period 2024-2030.

What is the Antipyretic Analgesics Market size in 2030?

Ans: The Antipyretic Analgesics Market size in 2030 will be US$ 3026.9 million.

Who are the main players in the Antipyretic Analgesics Market report?

Ans: The main players in the Antipyretic Analgesics Market are Mallinckrodt Pharmaceuticals, IOL, Anqiu Lu'an Pharmaceutical, Novacyl, BASF, Anhui BBCA Pharmaceuticals, Hubei Biocause, Xinhua Pharm, Granules India Limited, Huagang Pharm, Hebei Jiheng Pharmaceutical, Zhejiang Kangle Pharmaceutical, Hebei Jingye Medical Technology, MSPF

What are the Application segmentation covered in the Antipyretic Analgesics Market report?

Ans: The Applications covered in the Antipyretic Analgesics Market report are Adults, Children

What are the Type segmentation covered in the Antipyretic Analgesics Market report?

Ans: The Types covered in the Antipyretic Analgesics Market report are Paracetamol, Aspirin, Ibuprofen, Naproxen, Diclofenac, Oxaprozin, Dexibuprofen, Others

1 Antipyretic Analgesics Market Overview
1.1 Product Overview and Scope of Antipyretic Analgesics
1.2 Antipyretic Analgesics Segment by Type
1.2.1 Global Antipyretic Analgesics Market Value Comparison by Type (2024-2030)
1.2.2 Paracetamol
1.2.3 Aspirin
1.2.4 Ibuprofen
1.2.5 Naproxen
1.2.6 Diclofenac
1.2.7 Oxaprozin
1.2.8 Dexibuprofen
1.2.9 Others
1.3 Antipyretic Analgesics Segment by Application
1.3.1 Global Antipyretic Analgesics Market Value by Application: (2024-2030)
1.3.2 Adults
1.3.3 Children
1.4 Global Antipyretic Analgesics Market Size Estimates and Forecasts
1.4.1 Global Antipyretic Analgesics Revenue 2019-2030
1.4.2 Global Antipyretic Analgesics Sales 2019-2030
1.4.3 Global Antipyretic Analgesics Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Antipyretic Analgesics Market Competition by Manufacturers
2.1 Global Antipyretic Analgesics Sales Market Share by Manufacturers (2019-2024)
2.2 Global Antipyretic Analgesics Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Antipyretic Analgesics Average Price by Manufacturers (2019-2024)
2.4 Global Antipyretic Analgesics Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Antipyretic Analgesics, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Antipyretic Analgesics, Product Type & Application
2.7 Antipyretic Analgesics Market Competitive Situation and Trends
2.7.1 Antipyretic Analgesics Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Antipyretic Analgesics Players Market Share by Revenue
2.7.3 Global Antipyretic Analgesics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Antipyretic Analgesics Retrospective Market Scenario by Region
3.1 Global Antipyretic Analgesics Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Antipyretic Analgesics Global Antipyretic Analgesics Sales by Region: 2019-2030
3.2.1 Global Antipyretic Analgesics Sales by Region: 2019-2024
3.2.2 Global Antipyretic Analgesics Sales by Region: 2025-2030
3.3 Global Antipyretic Analgesics Global Antipyretic Analgesics Revenue by Region: 2019-2030
3.3.1 Global Antipyretic Analgesics Revenue by Region: 2019-2024
3.3.2 Global Antipyretic Analgesics Revenue by Region: 2025-2030
3.4 North America Antipyretic Analgesics Market Facts & Figures by Country
3.4.1 North America Antipyretic Analgesics Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Antipyretic Analgesics Sales by Country (2019-2030)
3.4.3 North America Antipyretic Analgesics Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Antipyretic Analgesics Market Facts & Figures by Country
3.5.1 Europe Antipyretic Analgesics Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Antipyretic Analgesics Sales by Country (2019-2030)
3.5.3 Europe Antipyretic Analgesics Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Antipyretic Analgesics Market Facts & Figures by Country
3.6.1 Asia Pacific Antipyretic Analgesics Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Antipyretic Analgesics Sales by Country (2019-2030)
3.6.3 Asia Pacific Antipyretic Analgesics Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Antipyretic Analgesics Market Facts & Figures by Country
3.7.1 Latin America Antipyretic Analgesics Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Antipyretic Analgesics Sales by Country (2019-2030)
3.7.3 Latin America Antipyretic Analgesics Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Antipyretic Analgesics Market Facts & Figures by Country
3.8.1 Middle East and Africa Antipyretic Analgesics Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Antipyretic Analgesics Sales by Country (2019-2030)
3.8.3 Middle East and Africa Antipyretic Analgesics Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Antipyretic Analgesics Sales by Type (2019-2030)
4.1.1 Global Antipyretic Analgesics Sales by Type (2019-2024)
4.1.2 Global Antipyretic Analgesics Sales by Type (2025-2030)
4.1.3 Global Antipyretic Analgesics Sales Market Share by Type (2019-2030)
4.2 Global Antipyretic Analgesics Revenue by Type (2019-2030)
4.2.1 Global Antipyretic Analgesics Revenue by Type (2019-2024)
4.2.2 Global Antipyretic Analgesics Revenue by Type (2025-2030)
4.2.3 Global Antipyretic Analgesics Revenue Market Share by Type (2019-2030)
4.3 Global Antipyretic Analgesics Price by Type (2019-2030)
5 Segment by Application
5.1 Global Antipyretic Analgesics Sales by Application (2019-2030)
5.1.1 Global Antipyretic Analgesics Sales by Application (2019-2024)
5.1.2 Global Antipyretic Analgesics Sales by Application (2025-2030)
5.1.3 Global Antipyretic Analgesics Sales Market Share by Application (2019-2030)
5.2 Global Antipyretic Analgesics Revenue by Application (2019-2030)
5.2.1 Global Antipyretic Analgesics Revenue by Application (2019-2024)
5.2.2 Global Antipyretic Analgesics Revenue by Application (2025-2030)
5.2.3 Global Antipyretic Analgesics Revenue Market Share by Application (2019-2030)
5.3 Global Antipyretic Analgesics Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Mallinckrodt Pharmaceuticals
6.1.1 Mallinckrodt Pharmaceuticals Corporation Information
6.1.2 Mallinckrodt Pharmaceuticals Description and Business Overview
6.1.3 Mallinckrodt Pharmaceuticals Antipyretic Analgesics Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Mallinckrodt Pharmaceuticals Antipyretic Analgesics Product Portfolio
6.1.5 Mallinckrodt Pharmaceuticals Recent Developments/Updates
6.2 IOL
6.2.1 IOL Corporation Information
6.2.2 IOL Description and Business Overview
6.2.3 IOL Antipyretic Analgesics Sales, Revenue and Gross Margin (2019-2024)
6.2.4 IOL Antipyretic Analgesics Product Portfolio
6.2.5 IOL Recent Developments/Updates
6.3 Anqiu Lu'an Pharmaceutical
6.3.1 Anqiu Lu'an Pharmaceutical Corporation Information
6.3.2 Anqiu Lu'an Pharmaceutical Description and Business Overview
6.3.3 Anqiu Lu'an Pharmaceutical Antipyretic Analgesics Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Anqiu Lu'an Pharmaceutical Antipyretic Analgesics Product Portfolio
6.3.5 Anqiu Lu'an Pharmaceutical Recent Developments/Updates
6.4 Novacyl
6.4.1 Novacyl Corporation Information
6.4.2 Novacyl Description and Business Overview
6.4.3 Novacyl Antipyretic Analgesics Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Novacyl Antipyretic Analgesics Product Portfolio
6.4.5 Novacyl Recent Developments/Updates
6.5 BASF
6.5.1 BASF Corporation Information
6.5.2 BASF Description and Business Overview
6.5.3 BASF Antipyretic Analgesics Sales, Revenue and Gross Margin (2019-2024)
6.5.4 BASF Antipyretic Analgesics Product Portfolio
6.5.5 BASF Recent Developments/Updates
6.6 Anhui BBCA Pharmaceuticals
6.6.1 Anhui BBCA Pharmaceuticals Corporation Information
6.6.2 Anhui BBCA Pharmaceuticals Description and Business Overview
6.6.3 Anhui BBCA Pharmaceuticals Antipyretic Analgesics Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Anhui BBCA Pharmaceuticals Antipyretic Analgesics Product Portfolio
6.6.5 Anhui BBCA Pharmaceuticals Recent Developments/Updates
6.7 Hubei Biocause
6.6.1 Hubei Biocause Corporation Information
6.6.2 Hubei Biocause Description and Business Overview
6.6.3 Hubei Biocause Antipyretic Analgesics Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Hubei Biocause Antipyretic Analgesics Product Portfolio
6.7.5 Hubei Biocause Recent Developments/Updates
6.8 Xinhua Pharm
6.8.1 Xinhua Pharm Corporation Information
6.8.2 Xinhua Pharm Description and Business Overview
6.8.3 Xinhua Pharm Antipyretic Analgesics Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Xinhua Pharm Antipyretic Analgesics Product Portfolio
6.8.5 Xinhua Pharm Recent Developments/Updates
6.9 Granules India Limited
6.9.1 Granules India Limited Corporation Information
6.9.2 Granules India Limited Description and Business Overview
6.9.3 Granules India Limited Antipyretic Analgesics Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Granules India Limited Antipyretic Analgesics Product Portfolio
6.9.5 Granules India Limited Recent Developments/Updates
6.10 Huagang Pharm
6.10.1 Huagang Pharm Corporation Information
6.10.2 Huagang Pharm Description and Business Overview
6.10.3 Huagang Pharm Antipyretic Analgesics Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Huagang Pharm Antipyretic Analgesics Product Portfolio
6.10.5 Huagang Pharm Recent Developments/Updates
6.11 Hebei Jiheng Pharmaceutical
6.11.1 Hebei Jiheng Pharmaceutical Corporation Information
6.11.2 Hebei Jiheng Pharmaceutical Antipyretic Analgesics Description and Business Overview
6.11.3 Hebei Jiheng Pharmaceutical Antipyretic Analgesics Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Hebei Jiheng Pharmaceutical Antipyretic Analgesics Product Portfolio
6.11.5 Hebei Jiheng Pharmaceutical Recent Developments/Updates
6.12 Zhejiang Kangle Pharmaceutical
6.12.1 Zhejiang Kangle Pharmaceutical Corporation Information
6.12.2 Zhejiang Kangle Pharmaceutical Antipyretic Analgesics Description and Business Overview
6.12.3 Zhejiang Kangle Pharmaceutical Antipyretic Analgesics Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Zhejiang Kangle Pharmaceutical Antipyretic Analgesics Product Portfolio
6.12.5 Zhejiang Kangle Pharmaceutical Recent Developments/Updates
6.13 Hebei Jingye Medical Technology
6.13.1 Hebei Jingye Medical Technology Corporation Information
6.13.2 Hebei Jingye Medical Technology Antipyretic Analgesics Description and Business Overview
6.13.3 Hebei Jingye Medical Technology Antipyretic Analgesics Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Hebei Jingye Medical Technology Antipyretic Analgesics Product Portfolio
6.13.5 Hebei Jingye Medical Technology Recent Developments/Updates
6.14 MSPF
6.14.1 MSPF Corporation Information
6.14.2 MSPF Antipyretic Analgesics Description and Business Overview
6.14.3 MSPF Antipyretic Analgesics Sales, Revenue and Gross Margin (2019-2024)
6.14.4 MSPF Antipyretic Analgesics Product Portfolio
6.14.5 MSPF Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Antipyretic Analgesics Industry Chain Analysis
7.2 Antipyretic Analgesics Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Antipyretic Analgesics Production Mode & Process
7.4 Antipyretic Analgesics Sales and Marketing
7.4.1 Antipyretic Analgesics Sales Channels
7.4.2 Antipyretic Analgesics Distributors
7.5 Antipyretic Analgesics Customers
8 Antipyretic Analgesics Market Dynamics
8.1 Antipyretic Analgesics Industry Trends
8.2 Antipyretic Analgesics Market Drivers
8.3 Antipyretic Analgesics Market Challenges
8.4 Antipyretic Analgesics Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
    Table 1. Global Antipyretic Analgesics Market Value Comparison by Type (2024-2030) & (US$ Million)
    Table 2. Global Antipyretic Analgesics Market Value Comparison by Application (2024-2030) & (US$ Million)
    Table 3. Global Antipyretic Analgesics Market Competitive Situation by Manufacturers in 2023
    Table 4. Global Antipyretic Analgesics Sales (MT) of Key Manufacturers (2019-2024)
    Table 5. Global Antipyretic Analgesics Sales Market Share by Manufacturers (2019-2024)
    Table 6. Global Antipyretic Analgesics Revenue (US$ Million) by Manufacturers (2019-2024)
    Table 7. Global Antipyretic Analgesics Revenue Share by Manufacturers (2019-2024)
    Table 8. Global Market Antipyretic Analgesics Average Price (USD/Kg) of Key Manufacturers (2019-2024)
    Table 9. Global Key Players of Antipyretic Analgesics, Industry Ranking, 2022 VS 2023 VS 2024
    Table 10. Global Key Manufacturers of Antipyretic Analgesics, Manufacturing Sites & Headquarters
    Table 11. Global Key Manufacturers of Antipyretic Analgesics, Product Type & Application
    Table 12. Global Key Manufacturers of Antipyretic Analgesics, Date of Enter into This Industry
    Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Antipyretic Analgesics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antipyretic Analgesics as of 2023)
    Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 16. Global Antipyretic Analgesics Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 17. Global Antipyretic Analgesics Sales by Region (2019-2024) & (MT)
    Table 18. Global Antipyretic Analgesics Sales Market Share by Region (2019-2024)
    Table 19. Global Antipyretic Analgesics Sales by Region (2025-2030) & (MT)
    Table 20. Global Antipyretic Analgesics Sales Market Share by Region (2025-2030)
    Table 21. Global Antipyretic Analgesics Revenue by Region (2019-2024) & (US$ Million)
    Table 22. Global Antipyretic Analgesics Revenue Market Share by Region (2019-2024)
    Table 23. Global Antipyretic Analgesics Revenue by Region (2025-2030) & (US$ Million)
    Table 24. Global Antipyretic Analgesics Revenue Market Share by Region (2025-2030)
    Table 25. North America Antipyretic Analgesics Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 26. North America Antipyretic Analgesics Sales by Country (2019-2024) & (MT)
    Table 27. North America Antipyretic Analgesics Sales by Country (2025-2030) & (MT)
    Table 28. North America Antipyretic Analgesics Revenue by Country (2019-2024) & (US$ Million)
    Table 29. North America Antipyretic Analgesics Revenue by Country (2025-2030) & (US$ Million)
    Table 30. Europe Antipyretic Analgesics Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 31. Europe Antipyretic Analgesics Sales by Country (2019-2024) & (MT)
    Table 32. Europe Antipyretic Analgesics Sales by Country (2025-2030) & (MT)
    Table 33. Europe Antipyretic Analgesics Revenue by Country (2019-2024) & (US$ Million)
    Table 34. Europe Antipyretic Analgesics Revenue by Country (2025-2030) & (US$ Million)
    Table 35. Asia Pacific Antipyretic Analgesics Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 36. Asia Pacific Antipyretic Analgesics Sales by Region (2019-2024) & (MT)
    Table 37. Asia Pacific Antipyretic Analgesics Sales by Region (2025-2030) & (MT)
    Table 38. Asia Pacific Antipyretic Analgesics Revenue by Region (2019-2024) & (US$ Million)
    Table 39. Asia Pacific Antipyretic Analgesics Revenue by Region (2025-2030) & (US$ Million)
    Table 40. Latin America Antipyretic Analgesics Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Latin America Antipyretic Analgesics Sales by Country (2019-2024) & (MT)
    Table 42. Latin America Antipyretic Analgesics Sales by Country (2025-2030) & (MT)
    Table 43. Latin America Antipyretic Analgesics Revenue by Country (2019-2024) & (US$ Million)
    Table 44. Latin America Antipyretic Analgesics Revenue by Country (2025-2030) & (US$ Million)
    Table 45. Middle East & Africa Antipyretic Analgesics Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 46. Middle East & Africa Antipyretic Analgesics Sales by Country (2019-2024) & (MT)
    Table 47. Middle East & Africa Antipyretic Analgesics Sales by Country (2025-2030) & (MT)
    Table 48. Middle East & Africa Antipyretic Analgesics Revenue by Country (2019-2024) & (US$ Million)
    Table 49. Middle East & Africa Antipyretic Analgesics Revenue by Country (2025-2030) & (US$ Million)
    Table 50. Global Antipyretic Analgesics Sales (MT) by Type (2019-2024)
    Table 51. Global Antipyretic Analgesics Sales (MT) by Type (2025-2030)
    Table 52. Global Antipyretic Analgesics Sales Market Share by Type (2019-2024)
    Table 53. Global Antipyretic Analgesics Sales Market Share by Type (2025-2030)
    Table 54. Global Antipyretic Analgesics Revenue (US$ Million) by Type (2019-2024)
    Table 55. Global Antipyretic Analgesics Revenue (US$ Million) by Type (2025-2030)
    Table 56. Global Antipyretic Analgesics Revenue Market Share by Type (2019-2024)
    Table 57. Global Antipyretic Analgesics Revenue Market Share by Type (2025-2030)
    Table 58. Global Antipyretic Analgesics Price (USD/Kg) by Type (2019-2024)
    Table 59. Global Antipyretic Analgesics Price (USD/Kg) by Type (2025-2030)
    Table 60. Global Antipyretic Analgesics Sales (MT) by Application (2019-2024)
    Table 61. Global Antipyretic Analgesics Sales (MT) by Application (2025-2030)
    Table 62. Global Antipyretic Analgesics Sales Market Share by Application (2019-2024)
    Table 63. Global Antipyretic Analgesics Sales Market Share by Application (2025-2030)
    Table 64. Global Antipyretic Analgesics Revenue (US$ Million) by Application (2019-2024)
    Table 65. Global Antipyretic Analgesics Revenue (US$ Million) by Application (2025-2030)
    Table 66. Global Antipyretic Analgesics Revenue Market Share by Application (2019-2024)
    Table 67. Global Antipyretic Analgesics Revenue Market Share by Application (2025-2030)
    Table 68. Global Antipyretic Analgesics Price (USD/Kg) by Application (2019-2024)
    Table 69. Global Antipyretic Analgesics Price (USD/Kg) by Application (2025-2030)
    Table 70. Mallinckrodt Pharmaceuticals Corporation Information
    Table 71. Mallinckrodt Pharmaceuticals Description and Business Overview
    Table 72. Mallinckrodt Pharmaceuticals Antipyretic Analgesics Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
    Table 73. Mallinckrodt Pharmaceuticals Antipyretic Analgesics Product
    Table 74. Mallinckrodt Pharmaceuticals Recent Developments/Updates
    Table 75. IOL Corporation Information
    Table 76. IOL Description and Business Overview
    Table 77. IOL Antipyretic Analgesics Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
    Table 78. IOL Antipyretic Analgesics Product
    Table 79. IOL Recent Developments/Updates
    Table 80. Anqiu Lu'an Pharmaceutical Corporation Information
    Table 81. Anqiu Lu'an Pharmaceutical Description and Business Overview
    Table 82. Anqiu Lu'an Pharmaceutical Antipyretic Analgesics Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
    Table 83. Anqiu Lu'an Pharmaceutical Antipyretic Analgesics Product
    Table 84. Anqiu Lu'an Pharmaceutical Recent Developments/Updates
    Table 85. Novacyl Corporation Information
    Table 86. Novacyl Description and Business Overview
    Table 87. Novacyl Antipyretic Analgesics Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
    Table 88. Novacyl Antipyretic Analgesics Product
    Table 89. Novacyl Recent Developments/Updates
    Table 90. BASF Corporation Information
    Table 91. BASF Description and Business Overview
    Table 92. BASF Antipyretic Analgesics Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
    Table 93. BASF Antipyretic Analgesics Product
    Table 94. BASF Recent Developments/Updates
    Table 95. Anhui BBCA Pharmaceuticals Corporation Information
    Table 96. Anhui BBCA Pharmaceuticals Description and Business Overview
    Table 97. Anhui BBCA Pharmaceuticals Antipyretic Analgesics Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
    Table 98. Anhui BBCA Pharmaceuticals Antipyretic Analgesics Product
    Table 99. Anhui BBCA Pharmaceuticals Recent Developments/Updates
    Table 100. Hubei Biocause Corporation Information
    Table 101. Hubei Biocause Description and Business Overview
    Table 102. Hubei Biocause Antipyretic Analgesics Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
    Table 103. Hubei Biocause Antipyretic Analgesics Product
    Table 104. Hubei Biocause Recent Developments/Updates
    Table 105. Xinhua Pharm Corporation Information
    Table 106. Xinhua Pharm Description and Business Overview
    Table 107. Xinhua Pharm Antipyretic Analgesics Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
    Table 108. Xinhua Pharm Antipyretic Analgesics Product
    Table 109. Xinhua Pharm Recent Developments/Updates
    Table 110. Granules India Limited Corporation Information
    Table 111. Granules India Limited Description and Business Overview
    Table 112. Granules India Limited Antipyretic Analgesics Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
    Table 113. Granules India Limited Antipyretic Analgesics Product
    Table 114. Granules India Limited Recent Developments/Updates
    Table 115. Huagang Pharm Corporation Information
    Table 116. Huagang Pharm Description and Business Overview
    Table 117. Huagang Pharm Antipyretic Analgesics Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
    Table 118. Huagang Pharm Antipyretic Analgesics Product
    Table 119. Huagang Pharm Recent Developments/Updates
    Table 120. Hebei Jiheng Pharmaceutical Corporation Information
    Table 121. Hebei Jiheng Pharmaceutical Description and Business Overview
    Table 122. Hebei Jiheng Pharmaceutical Antipyretic Analgesics Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
    Table 123. Hebei Jiheng Pharmaceutical Antipyretic Analgesics Product
    Table 124. Hebei Jiheng Pharmaceutical Recent Developments/Updates
    Table 125. Zhejiang Kangle Pharmaceutical Corporation Information
    Table 126. Zhejiang Kangle Pharmaceutical Description and Business Overview
    Table 127. Zhejiang Kangle Pharmaceutical Antipyretic Analgesics Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
    Table 128. Zhejiang Kangle Pharmaceutical Antipyretic Analgesics Product
    Table 129. Zhejiang Kangle Pharmaceutical Recent Developments/Updates
    Table 130. Hebei Jingye Medical Technology Corporation Information
    Table 131. Hebei Jingye Medical Technology Description and Business Overview
    Table 132. Hebei Jingye Medical Technology Antipyretic Analgesics Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
    Table 133. Hebei Jingye Medical Technology Antipyretic Analgesics Product
    Table 134. Hebei Jingye Medical Technology Recent Developments/Updates
    Table 135. MSPF Corporation Information
    Table 136. MSPF Description and Business Overview
    Table 137. MSPF Antipyretic Analgesics Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
    Table 138. MSPF Antipyretic Analgesics Product
    Table 139. MSPF Recent Developments/Updates
    Table 140. Key Raw Materials Lists
    Table 141. Raw Materials Key Suppliers Lists
    Table 142. Antipyretic Analgesics Distributors List
    Table 143. Antipyretic Analgesics Customers List
    Table 144. Antipyretic Analgesics Market Trends
    Table 145. Antipyretic Analgesics Market Drivers
    Table 146. Antipyretic Analgesics Market Challenges
    Table 147. Antipyretic Analgesics Market Restraints
    Table 148. Research Programs/Design for This Report
    Table 149. Key Data Information from Secondary Sources
    Table 150. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Antipyretic Analgesics
    Figure 2. Global Antipyretic Analgesics Market Value Comparison by Type (2024-2030) & (US$ Million)
    Figure 3. Global Antipyretic Analgesics Market Share by Type in 2023 & 2030
    Figure 4. Paracetamol Product Picture
    Figure 5. Aspirin Product Picture
    Figure 6. Ibuprofen Product Picture
    Figure 7. Naproxen Product Picture
    Figure 8. Diclofenac Product Picture
    Figure 9. Oxaprozin Product Picture
    Figure 10. Dexibuprofen Product Picture
    Figure 11. Others Product Picture
    Figure 12. Global Antipyretic Analgesics Market Value Comparison by Application (2024-2030) & (US$ Million)
    Figure 13. Global Antipyretic Analgesics Market Share by Application in 2023 & 2030
    Figure 14. Adults
    Figure 15. Children
    Figure 16. Global Antipyretic Analgesics Revenue, (US$ Million), 2019 VS 2023 VS 2030
    Figure 17. Global Antipyretic Analgesics Market Size (2019-2030) & (US$ Million)
    Figure 18. Global Antipyretic Analgesics Sales (2019-2030) & (MT)
    Figure 19. Global Antipyretic Analgesics Average Price (USD/Kg) & (2019-2030)
    Figure 20. Antipyretic Analgesics Report Years Considered
    Figure 21. Antipyretic Analgesics Sales Share by Manufacturers in 2023
    Figure 22. Global Antipyretic Analgesics Revenue Share by Manufacturers in 2023
    Figure 23. The Global 5 and 10 Largest Antipyretic Analgesics Players: Market Share by Revenue in 2023
    Figure 24. Antipyretic Analgesics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
    Figure 25. Global Antipyretic Analgesics Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Figure 26. North America Antipyretic Analgesics Sales Market Share by Country (2019-2030)
    Figure 27. North America Antipyretic Analgesics Revenue Market Share by Country (2019-2030)
    Figure 28. U.S. Antipyretic Analgesics Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 29. Canada Antipyretic Analgesics Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 30. Europe Antipyretic Analgesics Sales Market Share by Country (2019-2030)
    Figure 31. Europe Antipyretic Analgesics Revenue Market Share by Country (2019-2030)
    Figure 32. Germany Antipyretic Analgesics Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 33. France Antipyretic Analgesics Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 34. U.K. Antipyretic Analgesics Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 35. Italy Antipyretic Analgesics Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 36. Russia Antipyretic Analgesics Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 37. Asia Pacific Antipyretic Analgesics Sales Market Share by Region (2019-2030)
    Figure 38. Asia Pacific Antipyretic Analgesics Revenue Market Share by Region (2019-2030)
    Figure 39. China Antipyretic Analgesics Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 40. Japan Antipyretic Analgesics Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 41. South Korea Antipyretic Analgesics Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 42. India Antipyretic Analgesics Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 43. Australia Antipyretic Analgesics Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 44. Taiwan Antipyretic Analgesics Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 45. Indonesia Antipyretic Analgesics Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 46. Thailand Antipyretic Analgesics Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 47. Malaysia Antipyretic Analgesics Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 48. Philippines Antipyretic Analgesics Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 49. Latin America Antipyretic Analgesics Sales Market Share by Country (2019-2030)
    Figure 50. Latin America Antipyretic Analgesics Revenue Market Share by Country (2019-2030)
    Figure 51. Mexico Antipyretic Analgesics Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 52. Brazil Antipyretic Analgesics Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 53. Argentina Antipyretic Analgesics Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 54. Middle East & Africa Antipyretic Analgesics Sales Market Share by Country (2019-2030)
    Figure 55. Middle East & Africa Antipyretic Analgesics Revenue Market Share by Country (2019-2030)
    Figure 56. Turkey Antipyretic Analgesics Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 57. Saudi Arabia Antipyretic Analgesics Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 58. UAE Antipyretic Analgesics Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 59. Global Sales Market Share of Antipyretic Analgesics by Type (2019-2030)
    Figure 60. Global Revenue Market Share of Antipyretic Analgesics by Type (2019-2030)
    Figure 61. Global Antipyretic Analgesics Price (USD/Kg) by Type (2019-2030)
    Figure 62. Global Sales Market Share of Antipyretic Analgesics by Application (2019-2030)
    Figure 63. Global Revenue Market Share of Antipyretic Analgesics by Application (2019-2030)
    Figure 64. Global Antipyretic Analgesics Price (USD/Kg) by Application (2019-2030)
    Figure 65. Antipyretic Analgesics Value Chain
    Figure 66. Antipyretic Analgesics Production Process
    Figure 67. Channels of Distribution (Direct Vs Distribution)
    Figure 68. Distributors Profiles
    Figure 69. Bottom-up and Top-down Approaches for This Report
    Figure 70. Data Triangulation
    Figure 71. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Leap India

SIMILAR REPORTS